The limitation isn't pharmacokinetic stability
Cng ngh Liposome gip tng cng vic thm thu ca cc hot cht nano L-Glutathione - dng kh hot ng ca Glutathione vo su bn trong da thc y chng oxy ha, nga lo ha, hnh thnh cc sc t sng v c ch to hc sc t lm sng da t bn trong
GLP-1 receptors are widely expressed in myocardial and vascular systems 34 , and activation of these receptors may reduce cardiovascular risk by enhancing endothelial nitric oxide production 35,36 , modulating vascular tone, and reducing epicardial adipose tissue volume 37,38
These data support a risk-stratification framework in which exendin-4-based agents are considered to carry higher reported risk for immune-mediated pulmonary events, though the absolute incidence of these events in treated populations cannot be determined from the available evidence
It is not a medicine
By standardizing treatment sequencing, technical execution, timing, and delivery parameters, the protocol provides, for the first time, a reproducible framework that can be applied consistently across centers